Topic resource collection
Approved comparison material connected to this topic.
774 resourcesRead both sides
Recovery demands shift depending on whether you're bouncing back from a single 14er summit push or managing cumulative fatigue across a five-day backpacking trip. Single-event recovery prioritises acute inflammation control and t…
Before selecting a peptide, understand what each compound does best. And where it falls short. BPC-157 Upregulates growth factor receptors (VEGF, EGF) on fibroblasts; accelerates collagen synthesis in tendons and ligaments Achill…
BPC-157 VEGF upregulation, angiogenesis, FAK-paxillin signaling Tendon tears, ligament sprains, chronic tendinopathies 200–400 mcg/day subcutaneous Strong preclinical (rodent models), no human RCTs Gold standard for tendon/ligame…
TB-500 Actin upregulation in damaged myocytes Reduces shoulder and lat recovery time by 30–40% between high-volume sessions 2–2.5 mg twice weekly 7–10 days (cumulative) Best for swimmers logging >50k meters/week with chronic shou…
BPC-157 VEGF-mediated angiogenesis, accelerated tendon healing 250–500 mcg/day subcutaneous, 4–6 weeks ~4 hours Acute pulley injuries, tendon microtears Fastest tendon healing acceleration. Localized injection near injury site sh…
BPC-157 Upregulates VEGF and growth hormone receptors in tendons; accelerates fibroblast migration to injury sites Rotator cuff tendinopathy, golfer's elbow (medial epicondylitis), wrist flexor strain 200–400 mcg per injection, t…
The table below compares the peptides most frequently discussed in tinnitus research, focusing on mechanism, evidence quality, and practical considerations for research use. BPC-157 Reduces cochlear inflammation via cytokine modu…
BPC-157 Growth hormone receptor upregulation, FAK-paxillin pathway activation, collagen fiber organization 200–500mcg daily subcutaneous 4–6 weeks for tendon/ligament adaptation High affinity for tendon-to-bone junctions, gastric…
| Peptide | Primary Mechanism | Tissue Specificity | Typical Dosing | Fibrosis Reduction (vs Control) | Time to Measurable Effect | Professional Assessment ||—|—|—|—|—|—|| BPC-157 | VEGF upregulation, NO pathway activation, FAK-p…
BPC-157 Modulates inflammatory cytokines (TNF-α, IL-6); upregulates VEGF for angiogenesis; stabilises nitric oxide pathways 200–500 mcg daily subcutaneous for 4–6 weeks University of Zagreb study: reduced oxidative stress and pre…
NSAIDs (non-steroidal anti-inflammatory drugs like ibuprofen and naproxen) work by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), which block prostaglandin synthesis. The signaling molecules that trigger inflammation, pain,…
BPC-157 (pentadecapeptide) VEGF upregulation → angiogenesis and mucosal healing Animal studies show 60% faster gingival wound closure; human case reports in post-surgical healing Topical gel, subgingival injection, systemic subcu…
The peptides under investigation for retinal neuroprotection differ fundamentally in mechanism, administration route, and the stage of disease where intervention might theoretically work. Thymalin Immune modulation. Reduces T-cel…
Cerebrolysin Neurotrophic factor delivery (BDNF, NGF, CNTF) Protects vestibular neurons from oxidative stress and age-related degeneration Intramuscular or intravenous injection Refrigerate at 2–8°C; avoid temperature excursions …
The table below compares peptide categories by their primary mechanism, martial arts-specific benefit, typical research dosing range, and key practical considerations. This is clinical reference data. Not personal recommendations…
BPC-157 VEGF upregulation, angiogenesis, nitric oxide modulation Tendinopathy (tennis elbow, Achilles, rotator cuff) 200–500 mcg/day Twice daily (subcutaneous near injury site) Preclinical rodent studies; human case reports Stron…
BPC-157 VEGF upregulation, angiogenesis at fracture site 200–500 mcg daily, subcutaneous near injury 56% faster bone density recovery (J Orthop Res, 2019) Weeks 0–2 (inflammatory & early soft callus) Strongest evidence for early-…
Before selecting a peptide protocol, understanding mechanism, bioavailability, and clinical evidence is essential. Each peptide addresses distinct aspects of post-antibiotic damage. BPC-157 VEGF upregulation, tight junction repai…
Thymalin Restores thymic T-cell regulation; reduces cytokine storm (IL-6, TNF-α by 40–55%) Within 24 hours of symptom onset 5–10mg SC daily × 5–7 days Acute immune dysregulation (0–48 hours) Best choice for preventing immune over…
BPC-157 Upregulates VEGF, EGF, FGF receptors; promotes angiogenesis and collagen synthesis Rotator cuff tendinopathy, hand ligament microtrauma, TFCC damage Moderate (animal models, limited human trials) 200–500 mcg SubQ 2x daily…